Cytokinetics (CYTK)EVP Research & Development sold ~$215K

~$215K

Approx. value · 3,500 sh @ $61.38

154K

Holds after · shares reported

Traded

Oct 6, 2026

Filed

Oct 6, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Aug 10, 2026InsiderCEO sold ~$576K of CYTK shares in the open market
2. Aug 18, 2026InsiderOfficer sold ~$265K of CYTK shares in the open market
3. Aug 31, 2026Insider · 2 peopleInsiders: 2 sales (~$1.2M)
4. Sep 1, 2026InsiderDirector sold ~$357K of CYTK shares in the open market
5. Sep 8, 2026InsiderOfficer sold ~$264K of CYTK shares in the open market
6. Sep 11, 2026InsiderDirector sold ~$75K of CYTK shares in the open market
7. Sep 14, 2026InsiderCEO sold ~$551K of CYTK shares in the open market
8. Sep 15, 2026Insider · 2 peopleInsiders: 2 sales (~$6.9M)
9. Sep 22, 2026InsiderOfficer sold ~$239K of CYTK shares in the open market
10. Sep 28, 2026InsiderCEO sold ~$491K of CYTK shares in the open market
11. Oct 6, 2026 · this disclosureInsiderOfficer sold ~$215K of CYTK shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Cytokinetics

For Cytokinetics, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 11 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CYTK page.

Other recent filings by Fady Ibraham Malik, EVP Research & Development

• SEC Form 4 at Cytokinetics (CYTK)Sep 22, 2026
• SEC Form 4 at Cytokinetics (CYTK)Sep 8, 2026
• SEC Form 4 at Cytokinetics (CYTK)Aug 18, 2026
• SEC Form 4 at Cytokinetics (CYTK)Jul 23, 2026
• SEC Form 4 at Cytokinetics (CYTK)Jul 7, 2026

The full history of Fady Ibraham Malik, EVP Research & Development is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Cytokinetics

• SEC Form 4Sep 28, 2026
• SEC Form 4Sep 22, 2026
• SEC Form 4Sep 15, 2026
• SEC Form 4Sep 15, 2026
• SEC Form 4Sep 15, 2026
• SEC Form 4Sep 11, 2026

Everything OQRO holds on this company is on its CYTK page.